Global Kidney Stones Management Market

Kidney Stones Management Market Size, Share, Growth Analysis, By Treatment(ESWL, ureteroscopy, PCNL and others), By Type(Calcium oxalate, calcium phosphate, uric acid, struvite and cysteine), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2135 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 75

Kidney Stones Management Market Insights

Kidney Stones Management Market size was valued at USD 1.93 billion in 2022 and is poised to grow from USD 2.06 billion in 2023 to USD 3.55 billion by 2031, at a CAGR of 7% during the forecast period (2024-2031).

Global Kidney Stones Management Market is a thriving and dynamic sector in the healthcare industry, poised for continued growth in the present era. Characterized by an increasing prevalence of kidney stone cases worldwide, this market is witnessing a surge in demand for effective and innovative treatment solutions. Presently, cutting-edge technologies and advanced medical procedures such as shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy are widely adopted for efficient stone removal, promoting quicker recovery times and reduced patient discomfort. Additionally, the market is experiencing a significant upswing in minimally invasive techniques, such as laser lithotripsy and robotic-assisted surgeries, offering precise stone targeting and enhanced patient outcomes. Furthermore, a growing focus on research and development activities by key industry players has resulted in the introduction of novel pharmaceuticals aimed at preventing stone recurrence and managing pain associated with kidney stones. Geographically, North America hold substantial market shares due to the high incidence of kidney stone cases and favorable reimbursement policies. However, the Asia-Pacific region is expected to witness the fastest growth rate during the present period, attributed to increasing healthcare infrastructure, rising awareness, and improved accessibility to advanced treatment options. In conclusion, the global market is currently characterized by technological advancements, growing adoption of minimally invasive procedures, and significant regional expansion, indicating a promising outlook for the industry's future.

US Kidney Stones Management Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Kidney Stones Management Market size was valued at USD 1.93 billion in 2022 and is poised to grow from USD 2.06 billion in 2023 to USD 3.55 billion by 2031, at a CAGR of 7% during the forecast period (2024-2031).

The competitive landscape of the Global Kidney Stones Management Market is characterized by intense rivalry among key market players striving to enhance their market positions. These companies are focusing on research and development activities to introduce innovative treatment options and technologies for efficient kidney stone management. Additionally, partnerships, collaborations, and strategic acquisitions are common strategies employed by players to expand their product portfolios and geographical reach. With a strong emphasis on addressing the increasing demand for effective kidney stone treatments, the market is witnessing continuous advancements and a constant drive to improve patient outcomes. Regulatory approvals and compliance play a significant role in shaping the competitive dynamics of the market, as companies aim to gain a competitive edge by adhering to stringent quality and safety standards. 'Siemens Healthineers AG (Germany)', 'Inceler Medikal Co. Ltd. (Turkey)', 'DirexGroup (Israel)', 'EDAP TMS S.A. (France)', 'Dornier MedTech (Subsidiary of Accuron MedTech) (Germany)', 'Lumenis Ltd. (Israel)', 'GEMSS Co. Ltd. (South Korea)', 'Richard Wolf GmbH (Germany)', 'STORZ MEDICAL AG (Switzerland)', 'Olympus Corporation (Japan)', 'Boston Scientific Corporation (US)', 'Stryker Corporation (US)', 'Medtronic plc (Ireland)', 'Cook Medical LLC (US)', 'Coloplast Group (Denmark)', 'Karl Storz SE & Co. KG (Germany)', 'Allengers Medical Systems Ltd. (India)', 'Convergent Laser Technologies (US)', 'Novamedtek (Turkey)', 'Quanta System S.p.A. (Italy)'

One key driver of the Global Kidney Stones Management Market is the increasing prevalence of kidney stone cases worldwide. The rising incidence of kidney stones is contributing to a growing demand for effective treatment solutions, leading to the development of advanced medical technologies and innovative procedures. As the number of individuals affected by kidney stones continues to increase, there is a greater focus on research and development efforts to improve existing treatment options and introduce new interventions, driving the growth of the market.

Increasing adoption of robotic-assisted surgeries for kidney stone removal: One key market trend in the Global Kidney Stones Management Market is the increasing adoption of robotic-assisted surgeries for kidney stone removal. Robotic platforms, such as Ethicon's MONARCH platform mentioned in the news release, are gaining popularity in the field of urology due to their precision and ability to reduce the risk of complications during procedures. The integration of robotic technology allows for more accurate and controlled maneuvers, leading to improved patient outcomes and potentially minimizing the need for retreatment after kidney stone removal surgeries. This trend reflects the industry's continuous efforts to embrace advanced technologies that enhance the efficacy and safety of kidney stone management procedures.

The dominant region in the Global Kidney Stones Management Market is North America. North America holds the largest market share due to several factors, including a high prevalence of kidney stone cases, well-established healthcare infrastructure, advanced medical technologies, and a strong emphasis on research and development. The region's robust healthcare system facilitates early diagnosis and access to a wide range of treatment options, contributing to the prominence of North America in the kidney stones management market. Additionally, favorable reimbursement policies and increased awareness among patients and healthcare professionals further bolster the market's growth in this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Kidney Stones Management Market

Report ID: SQMIG35D2135

$5,300
BUY NOW GET FREE SAMPLE